Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0240
-0.0012 (-4.76%)
At close: Dec 5, 2025
Galera Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cash & Equivalents | 4.47 | 8.29 | 18.26 | 4.27 | 19.86 | 15.87 | Upgrade |
Short-Term Investments | - | - | - | 27.33 | 51.36 | 56.9 | Upgrade |
Cash & Short-Term Investments | 4.47 | 8.29 | 18.26 | 31.6 | 71.22 | 72.78 | Upgrade |
Cash Growth | -47.10% | -54.60% | -42.22% | -55.63% | -2.14% | -35.19% | Upgrade |
Other Receivables | - | 0.64 | - | 3.24 | - | - | Upgrade |
Receivables | - | 0.64 | - | 3.24 | - | - | Upgrade |
Prepaid Expenses | 0.43 | 1.08 | 3.37 | 3.65 | 6.18 | 5.15 | Upgrade |
Restricted Cash | - | - | - | 0.05 | - | - | Upgrade |
Total Current Assets | 4.9 | 10 | 21.63 | 38.54 | 77.39 | 77.93 | Upgrade |
Property, Plant & Equipment | - | - | 1.28 | 0.48 | 0.82 | 1.55 | Upgrade |
Goodwill | - | - | 0.88 | 0.88 | 0.88 | 0.88 | Upgrade |
Other Intangible Assets | - | - | 2.26 | 2.26 | 2.26 | 2.26 | Upgrade |
Other Long-Term Assets | 0.1 | 0.1 | 0.09 | 1.88 | 1.96 | 1.48 | Upgrade |
Total Assets | 5 | 10.1 | 26.14 | 44.04 | 83.31 | 84.1 | Upgrade |
Accounts Payable | 0.43 | 1.28 | 1.38 | 3.58 | 5.04 | 5.15 | Upgrade |
Accrued Expenses | 0.16 | 0.39 | 3.45 | 9.75 | 7.63 | 8.58 | Upgrade |
Current Portion of Leases | - | - | 0.13 | 0.04 | 0.26 | 0.24 | Upgrade |
Total Current Liabilities | 0.6 | 1.67 | 4.96 | 13.38 | 12.94 | 13.97 | Upgrade |
Long-Term Debt | 151.05 | 151.05 | 151.05 | 139.64 | 128.06 | - | Upgrade |
Long-Term Leases | - | - | 1.12 | - | 0.04 | 0.3 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | 0.2 | 0.2 | 0.27 | 0.27 | Upgrade |
Other Long-Term Liabilities | - | 1.06 | - | - | - | 63.44 | Upgrade |
Total Liabilities | 151.65 | 153.77 | 157.33 | 153.22 | 141.32 | 77.98 | Upgrade |
Common Stock | 0.08 | 0.08 | 0.05 | 0.03 | 0.03 | 0.03 | Upgrade |
Additional Paid-In Capital | 311.12 | 308.25 | 306.17 | 269.14 | 258.09 | 241.65 | Upgrade |
Retained Earnings | -460.42 | -456.36 | -437.41 | -378.32 | -316.1 | -235.57 | Upgrade |
Comprehensive Income & Other | - | - | - | -0.02 | -0.01 | 0.01 | Upgrade |
Total Common Equity | -149.22 | -148.04 | -131.19 | -109.18 | -58 | 6.12 | Upgrade |
Shareholders' Equity | -146.65 | -143.67 | -131.19 | -109.18 | -58 | 6.12 | Upgrade |
Total Liabilities & Equity | 5 | 10.1 | 26.14 | 44.04 | 83.31 | 84.1 | Upgrade |
Total Debt | 151.05 | 151.05 | 152.3 | 139.68 | 128.37 | 0.53 | Upgrade |
Net Cash (Debt) | -146.58 | -142.76 | -134.04 | -108.08 | -57.15 | 72.24 | Upgrade |
Net Cash Growth | - | - | - | - | - | -35.19% | Upgrade |
Net Cash Per Share | -1.67 | -2.61 | -3.01 | -3.99 | -2.22 | 2.90 | Upgrade |
Filing Date Shares Outstanding | 75.46 | 75.46 | 54.39 | 42.83 | 26.8 | 24.98 | Upgrade |
Total Common Shares Outstanding | 75.46 | 75.46 | 54.39 | 28.51 | 26.46 | 24.98 | Upgrade |
Working Capital | 4.3 | 8.34 | 16.67 | 25.16 | 64.46 | 63.96 | Upgrade |
Book Value Per Share | -1.98 | -1.96 | -2.41 | -3.83 | -2.19 | 0.24 | Upgrade |
Tangible Book Value | -149.22 | -148.04 | -134.32 | -112.32 | -61.14 | 2.98 | Upgrade |
Tangible Book Value Per Share | -1.98 | -1.96 | -2.47 | -3.94 | -2.31 | 0.12 | Upgrade |
Machinery | - | - | 0.48 | 1.87 | 1.85 | 1.57 | Upgrade |
Leasehold Improvements | - | - | 0.05 | 0.27 | 0.26 | 0.26 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.